Year: 2015
Type: article
Abstract: The authors review the nature of the proposal by the FDA for the regulation of next-generation sequencing and laboratory-developed tests in clinical medicine and offer thoughts on what is needed to protect consumers and foster innovation.
Source: New England Journal of Medicine
Authors: Barbara J. Evans, Wylie Burke, Gail P. Jarvik
Institutions: University of Washington, University of Houston
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2327499427
